When Should Breast Cancer Risk Scores Trigger MRI?
A JAMA Internal Medicine Viewpoint urges clinicians and health systems to verify risk-model inputs before acting on automated breast cancer screening recommendations.
By
Kerri Miller
June 23, 2026
Clinical Scorecard: When Should Breast Cancer Risk Scores Trigger MRI?
At a Glance
Category Detail
Condition Breast Cancer Risk Assessment Key Mechanisms Risk-based screening models and thresholds for MRI recommendations. Target Population American women assessed for breast cancer risk. Care Setting Primary care and radiology.
Key Highlights
5.6% of women exceed the 20% lifetime breast cancer risk threshold using the Tyrer-Cuzick model. Discrepancies exist between different risk assessment models. Primary care physicians must validate automated risk scores before acting. No consensus on high-risk definitions or screening intervals. Interdisciplinary working groups are needed to standardize models and thresholds. Guideline-Based Recommendations
Diagnosis
Utilize risk assessment models to evaluate breast cancer risk. Management
Confirm inputs of risk models before making MRI recommendations. Monitoring & Follow-up
Monitor discrepancies in risk assessments and their clinical implications. Risks
Incomplete data can lead to incorrect risk assessments and recommendations. Patient & Prescribing Data
Women undergoing breast cancer risk assessment.
Preventive medications reduce incidence but not mortality.
Clinical Best Practices
Validate automated risk scores with clinical context. Engage in interdisciplinary discussions to establish clear guidelines. Related Resources & Content
